Loading...
Loading...

Compliance Chat

A weekly newsletter on the latest compliance issues and how those issues are affecting therapy providers.

  • Always Therapy

    On July 27th, CMS released a Medicare Learning Matters on use of the "Always Therapy" modifiers when billing therapy services under Medicare Part B.  The modification, CR 10176, involves the use of always therapy modifiers, GN, GO, and GP and goes into effect on 1/1/18.  

    Read more...

  • Operational Vs Clinical Need

    Recently the Department of Justice announced a settlement against a provider of Rehabilitation Services that can once again provide us with potential lessons to learn.

    Read more...

  • Opioid Use

    Recently the OIG released a study of opioid prescriptions under Medicare Part D. You could be thinking, "Tom, what does this have to do with me?"

    Read more...

  • Healthcare Reform Update

    The roller coaster ride of healthcare reform continues with the U.S. Senate's recent release of their version of a healthcare reform law.

    Read more...

  • Being Prepared

    Periodically we use the Chat to report on findings involving Rehab providers.  We do this inform about enforcement trends we've observed and to hopefully provide a learning opportunity from the unfortunate mistakes of others. 

    Read more...

  • New ABN Form Released

    Recently, CMS released a revised ABN form, which is effective 6/21/2017.  This is what we will chat about today. 

    Read more...

  • Locum Tenens Use

    Where has the time gone! It's been a little over six months since the law was passed giving PT's the ability to bill for services under locum tenens. CMS was supposed to implement this ability by 6/13/17. So where are we?

    Read more...

  • Good News!

    Recently on 5/25/17 CMS announced Medicare will cover "Supervised Exercise Set", SET for Peripheral Artery Disease, PAD.  This can be good news for therapists and practices who understand how to take advantage of this expansion in coverage.

    Read more...

SHARE US ON: